Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer de Verneuil Vanina
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer O'Byrne Jason
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer de Verneuil Vanina
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer de Verneuil Vanina
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director SCANGOS GEORGE A
Vir Biotechnology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION :(4.1%)
Vir Biotechnology | 3: Initial statement of beneficial ownership of securities-Officer O'Byrne Jason
Vir Biotechnology | 3: Initial statement of beneficial ownership of securities-Officer Sabatini Brent
Vir Biotechnology | 3: Initial statement of beneficial ownership of securities-Officer de Verneuil Vanina
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Napolitano Janet
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Eisner Mark
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer De Backer Marianne
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Ramasastry Saira
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Sigal Charles Elliott
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director SCANGOS GEORGE A
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director SATO VICKI L
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Ramasastry Saira
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director NELSEN ROBERT
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Napolitano Janet
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director MORE ROBERT J